Cardinal Health, Inc. (CAH) Stock

About Cardinal Health, Inc.

Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, Europe, Asia, and other international markets. The company delivers bespoke support to a diverse clientele, including hospitals, healthcare networks, pharmacies, outpatient surgical centers, clinical labs, physician practices, and individuals receiving care at home. It is structured into two core divisions: Pharmaceutical and Medical. The Pharmaceutical division oversees the distribution of a wide array of products, encompassing branded, generic, and specialty pharmaceuticals, along with over-the-counter health and consumer goods. This segment additionally offers specialized services to pharmaceutical manufacturers and healthcare providers, particularly for specialty pharmaceutical products. Its operations extend to managing nuclear pharmacies and facilities that produce radiopharmaceuticals. It also performs repackaging of generic drugs and OTC items. Further offerings include medication therapy management and patient outcomes services for hospitals, other healthcare providers, and payers, in addition to providing pharmacy management solutions to hospitals. The Medical division focuses on producing, sourcing, and supplying Cardinal Health-branded medical, surgical, and laboratory products and devices. This extensive product range encompasses items such as examination and surgical gloves, needles, syringes, sharps disposal units, compression products, incontinence aids, nutritional delivery systems, wound care supplies, single-use drapes, gowns, and apparel, fluid suction and collection devices, urological products, operating room essentials, and electrodes. Beyond its proprietary brands, this segment also distributes various national brand medical, surgical, and laboratory products. It offers comprehensive supply chain management for hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare organizations, and manufactures and sells both sterile and non-sterile procedure kits. Established in 1979, the company maintains its headquarters in Dublin, Ohio.

Cardinal Health, Inc. is led by CEO Jason Hollar, employs 57,700 people, headquartered in Dublin, US, publicly traded since 1983.

Cardinal Health, Inc. (CAH) stock trades at $229.12 with a market capitalization of $53.66B. The stock is valued at a price-to-earnings (P/E) ratio of 34.93, price-to-book of -19.01, price-to-sales of 0.21. Over the past 52 weeks the stock has ranged between $137.75 and $243.21, and currently trades 5.8% below its 52-week high. It pays a dividend yielding 0.89%.

On profitability, Cardinal Health, Inc. generates a return on equity (ROE) of -55.72%, return on capital employed of 15.73%, an operating margin of 0.92%, a net profit margin of 0.62%.

In its most recent fiscal year, Cardinal Health, Inc. reported annual revenue of $222.6B, net profit of $1.6B, revenue has compounded at 7.8% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of -3.15 — a conservative balance sheet with little leverage risk, a current ratio of 0.94, total assets of $53.1B, $3.9B in cash and equivalents.

CAH has an average daily trading volume of 2,423,227 shares, a beta of 0.49 (less volatile than the overall market).

Official website: www.cardinalhealth.com